7 Tesla MRI Evaluation of the Spine
1 other identifier
observational
600
1 country
1
Brief Summary
High-resolution MRI (7 Tesla) of the spine is capable to differentiate osseous spurs from discus-material and better depict the compressed nerve in the neuroforamen compared to 3T MRI. Provide the surgeon with a detailed high-resolution anatomical image before surgery and potential no need for CT (if the bony anatomy is of crucial importance).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2020
CompletedFirst Submitted
Initial submission to the registry
June 19, 2020
CompletedFirst Posted
Study publicly available on registry
June 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
July 15, 2026
July 1, 2026
7.6 years
June 19, 2020
July 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
differentiation of compressed nerves in neuroforamen (7T vs 3T)
2 years
Interventions
7 Tesla MRI of the spine
Eligibility Criteria
Patients who have undergone a MRI of the spine for clinical indications will be enrolled through consecutive ongoing recruitment in daily clinical practice at Balgrist University Hospital Zurich.
You may qualify if:
- Informed consent as documented by signature (Appendix Informed Consent Form)
- \>18 years old
- Patients presenting chronic back pain (\> 2 months) without recent trauma, previous MRI (1,5 or 3T) for clinicals indications or asymptomatic individuals (for depicting normal microanatomy)
You may not qualify if:
- previous surgery
- tumor patients
- pregnancy or breast feeding
- any MRI contra-indications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Reto Sutter, MDlead
Study Sites (1)
Balgrist University Hospital
Zurich, Canton of Zurich, 8008, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- chief of radiology
Study Record Dates
First Submitted
June 19, 2020
First Posted
June 22, 2020
Study Start
March 4, 2020
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
July 15, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share